2m 2m 2m 2m 2m 2m 2m
- $36.3MMarket Cap
- 6.45%1-Year Change
- Medical DevicesIndustry
NEUROONE MD TCH (NMTC)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 74
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
NeuroOne Q3 Revenue Jumps 105 Percent
NeuroOne Medical Technologies reported strong Q3 2025 performance with 105% product revenue growth, improved gross margins, and promising clinical milestones for its OneRF ablation system, including the first patient achieving 12-month seizure freedom.
08/14/2025, 11:03 AM • The Motley Fool
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.
Key Executives
- David A. Rosa
- Christopher R. Volker
- Ronald W. McClurg
- Steven Mertens
- Mark Christianson
Current Ownership Distribution
- Institutions81.3M (75.15%)
- Insiders16.0M (14.80%)
- Mutual Funds10.9M (10.05%)
- Other0 (0.00%)